Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia

GOTHENBURG, Sweden, Aug. 13, 2020 /PRNewswire/ — Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced that it entered into a license agreement with Solasia Pharma K.K (“Solasia”) (TSE: 4597), to develop and commercialize Isofol’s…


Read More